Skinuvita

Private

BremenHealthcare & Life Scienceshttps://www.skinuvita.de/

Last Round

Seed

Dec 1, 2023

Total Funding Raised

$90,000

Company Overview

Skinuvita is a healthcare technology company that provides a home-based, medically supervised light therapy system for treating chronic skin conditions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

home phototherapydigital therapeuticsDTxteledermatologyUV phototherapypsoriasis treatmentatopic dermatitis treatmenttelemedicineeczema treatmentconnected medical devicedigital healthremote patient monitoringCE-certified medical devicehealth insurance reimbursementdermatology software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skinuvita Comps

Public and private peers based on sector, stage, and business model.

Skinuvita comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Skinuvita Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 1, 2023
Accelerator	Jan 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Jan B. Elsner

Founder & CEO

Founding Team

Skinuvita Investors

Notable investors and investment history

Skinuvita investors
Investor	Rounds
Die BrückenKöpfe	Seed
BAB Beteiligungs- und Managementgesellschaft Bremen mbH	Seed
High-Tech Gründerfonds	Seed
Vision Health Pioneers	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors increased 330% MoM.
Jan 6, 2026
Monthly visitors increased 45% MoM.

View all signals

Skinuvita Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Skinuvita Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Skinuvita's valuation, stock price, and market status.

Firmographic Details

HeadquartersBremen

Employee Range16

Year Founded2021

Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.